SurgicEye is collaborating with leading European research organizations on an EU funded research project.

With a large background in advanced navigation and image visualization especially in radio-guided surgery, SurgicEye is excited to take part in research looking towards integrated tools, the future for the treatment of cancer. The development of new, higher performance, and intra-operative applicable imaging techniques with multimodal capability will allow endoscopic procedures in diagnostic and therapeutic endoscopy and in surgical oncology. All of these applications are aiming at diagnosing and treating more patients with earlier tumor stages and improving patient outcome and therapy safety, as well as reducing healthcare costs.

ENDO-TOFPET_US research partners include:

• Universite de la Mediterranee, Aix-Marseille
• European Organization for Nuclear Research (CERN)
• Centre Hospitalier Universitaire Vaudois et Universite de Lausanne
• Deutsches Elektronen-Synchrotron
• Delft Technical University
• Fibercryst
• Kloe SA
• Laboratorio de Instrumentacao e Fisica Experimental de Particulas
• Technische Universitat Muenchen
• University of Heidelberg
• University Milano Biccoca

SurgicEye will engineer new solutions for receiving and visualizing nuclear signals from an endoscopic probe. In the final stages, nuclear and ultrasonic images will be combined, creating a new method of navigating and visualizing with an endoscope.

At the completion of this project, SurgicEye looks forward to building on the relationships and experience gained through this research in order to begin working towards a widely available and usable device for minimally invasive and safe surgical oncology.

This research is supported by the European Commission Cooperation FP7 Work Program under the Health sub category.

About SurgicEye GmbH:
SurgicEye offers solutions for intra-operative 3-D imaging and instrument navigation. The recent product declipseSPECT of SurgicEye implements the so called freehand SPECT technology for detection, localization and guided biopsy of sentinel lymph nodes in breast cancer and melanoma. Clinical investigations in other tumor surgery domains promise a wide application domain and huge potential for quality assurance during surgery. It enables surgical procedures to be more sensitive, more reliable and less invasive.

Contact:
SurgicEye GmbH
Dr. Thomas Wendler
Friedenstraße 18a
81671 Munich
Germany
Phone: +49-89-549-9890-00
Fax: +49-89-549-9890-90
E-Mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Internet: www.surgiceye.com